{"image_url":null,"blog_url":"https://uneyama.hatenadiary.jp/","height":"190","title":"1,2,4-\u30c8\u30ea\u30d2\u30c9\u30ed\u30ad\u30b7\u30d9\u30f3\u30bc\u30f3\u306b\u95a2\u3059\u308b\u610f\u898b","provider_name":"Hatena Blog","url":"https://uneyama.hatenadiary.jp/entry/20060525/p15","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","type":"rich","version":"1.0","description":"Opinion on 1,2,4-Trihydroxybenzene COLIPA N\u00b0 A33 Adopted by the SCCP during the 7th plenary meeting of 28 March 2006 http://ec.europa.eu/comm/health/ph_risk/committees/04_sccp/docs/sccp_o_041.pdf","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20060525%2Fp15\" title=\"1,2,4-\u30c8\u30ea\u30d2\u30c9\u30ed\u30ad\u30b7\u30d9\u30f3\u30bc\u30f3\u306b\u95a2\u3059\u308b\u610f\u898b - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_url":"https://blog.hatena.ne.jp/uneyama/","categories":[],"provider_url":"https://hatena.blog","published":"2006-05-25 00:00:15","author_name":"uneyama","width":"100%"}